Korea Stocks — 21 / 36

Korea Stocks, page 21 of 36 — 24 articles published 2026-07-30 ~ 2026-08-02.

August 2, 2026

Humedix (KRX 200670) Stock Outlook 2026: A Prescription Cash Cow Wearing an Aesthetics Growth Costume

Humedix (KRX: 200670) 2026 stock outlook, analyzed qualitatively. A hyaluronic-acid platform spans a defensive prescription cash cow — the Hyruan osteoarthritis knee injection — and a cyclical aesthetics growth engine in Elravie dermal fillers, plus toxin expansion, CDMO, and Huons Group distribution. We weigh the moat, the China NMPA export lever, and the competitive risks from LG Chem, Hugel and Jetema.

Humedix 200670 Korea Stocks

August 1, 2026

Able CnC (KOSDAQ 078520) Stock Outlook 2026: MISSHA Rebrand Turnaround vs Road-Shop Decline

Able CnC (KOSDAQ 078520) 2026 stock outlook. A deep look at the MISSHA and A'PIEU brand rebrand, the shift from single-brand road shops to Olive Young health-and-beauty, online and Japan exports, structural road-shop decline, the IMM PE ownership overhang, valuation and margin volatility, benchmarked against Clio and Tonymoly.

Able CnC MISSHA A'PIEU

August 1, 2026

Hanjin Transportation (002320) Stock Outlook 2026: The Logistics Moat, the Daejeon Mega Hub, and Hidden Real Estate Value

Hanjin Transportation (002320) 2026 stock outlook. A deep look at the Hanjin parcel network, port and global forwarding operations, the Daejeon Smart Mega Hub CAPEX recovery, e-commerce volume growth, hidden real estate value, and the risks from parcel price competition and Coupang's in-house logistics.

Hanjin 002320 Hanjin Parcel

August 1, 2026

STX Engine (077970) Stock Outlook 2026: The Shipbuilding Supercycle Meets a Defense Engine

STX Engine (KOSPI 077970) 2026 stock outlook. A qualitative deep dive into its dual structure of marine medium-speed diesel engines and defense power packs, the shipbuilding supercycle and dual-fuel (LNG/methanol) engine demand, steel-plate cost, FX and order-cycle risk, and how it stacks up against Hanwha Engine, HD Hyundai Heavy and Doosan Enerbility.

STX Engine 077970 Korea Stocks

August 1, 2026

Il-Yang Pharm (007570) Stock Outlook 2026: Homegrown Novel Drugs, Royalties, and the Russia Question

Il-Yang Pharmaceutical (KOSPI 007570) 2026 stock outlook. A deep look at its self-developed novel drugs Noltec (anti-ulcer) and Supect (leukemia targeted therapy), the P-CAB anti-ulcer competition with K-CAB and Fexuclue, Russia export exposure, vaccine and API business, and the structural risk of leaning on a narrow pipeline.

Il-Yang Pharm 007570 Korea Stocks

August 1, 2026

Binex (KOSDAQ 053030) Stock Outlook 2026: Flexible Bio CDMO vs Utilization Swings

Binex (053030) 2026 stock outlook. A deep qualitative look at the Korean biopharma CMO/CDMO model (antibody mammalian and microbial fermentation), small-batch multi-product flexibility versus Samsung Biologics scale, low-margin chemical drugs, and utilization and backlog volatility.

Binex 053030 Korea Stocks

August 1, 2026

Hwacheon Machinery (010660) Stock Outlook 2026: A Net-Cash Deep-Value Machine-Tool Play

Hwacheon Machinery (KOSPI 010660) 2026 stock outlook. A deep dive into its CNC lathe and machining-center business, the net-cash and low-PBR deep-value asset thesis, capex-cycle leverage from automation, defense and aerospace demand, and the risk from a weak yen and Japanese and Taiwanese rivals.

Hwacheon Machinery 010660 machine tools

August 1, 2026

NICE Information Service (030190) Stock Outlook 2026: The Credit-Data Monopoly Meets Its Growth Test

NICE Information Service (KOSPI 030190) 2026 stock outlook. A deep qualitative look at Korea's credit bureau (CB) duopoly, the regulatory moat and data-network effect, the cyclicality of recurring inquiry revenue, and the MyData, alternative-scoring, AI and data-sales growth story versus regulation and lending-cycle risk.

NICE Information Service 030190 Credit Bureau

August 1, 2026

Kyobo Securities (030610) Stock Outlook 2026: A High-Dividend, Low-PBR Value-Up Candidate With Real-Estate PF Tail Risk

Kyobo Securities (KOSPI 030610) 2026 stock outlook. A deep qualitative look at the mid-cap Korean broker's bond-trading and IB strengths, its appeal as a high-dividend low-PBR value-up candidate, real-estate project-finance (PF) provisioning and funding-cost risk, and how it stacks up against Daishin, Hanwha and Yuanta.

Kyobo Securities 030610 Korean brokers

August 1, 2026

KPX Chemical (025000) Stock Outlook 2026: Polyol Oligopoly and the Defensive Cyclical Puzzle

KPX Chemical (KOSPI 025000) 2026 stock outlook. A qualitative deep dive into its domestic polyol (PPG) and propylene glycol oligopoly, the PO/PG spread cycle, furniture, auto-seat and insulation demand, net-cash low-PBR defense, and the China oversupply risk.

KPX Chemical 025000 Korea Stocks

August 1, 2026

SFA Semicon (036540) Stock Outlook 2026: Memory Back-End OSAT Between the HBM Tailwind and Customer Concentration

SFA Semicon (036540) 2026 stock analysis: a Korea-listed memory OSAT doing DRAM and NAND packaging and test, its SiP, BGA and flip-chip capabilities, how Samsung and SK Hynix capex plus the HBM and advanced-packaging shift drive the back-end, parent SFA automation synergy, concentrated domestic customers, commodity packaging price competition, memory-cycle exposure, and how foreign investors reach a KOSPI-listed subcontractor.

SFA Semicon 036540 OSAT

July 31, 2026

Cube Entertainment (182360) Stock Outlook 2026: The Two Faces of a Single-IP K-Pop Bet

Cube Entertainment (KOSDAQ 182360) 2026 stock outlook. A qualitative deep dive into the (G)I-DLE-centric K-pop revenue model, albums, tours, merch and fan platforms, its scale and concentration versus HYBE, JYP, SM and YG, contract-renewal and comeback risks, and how foreign investors ride the theme through Korean equities and KRW FX.

Cube Entertainment 182360 K-pop

July 31, 2026

Lotte Insurance (000400) Stock Outlook 2026: CSM Growth and the Sale That Won't Stay Quiet

Lotte Insurance (KOSPI 000400) 2026 stock outlook for foreign investors. IFRS17 CSM growth and long-term protection mix, the JKL Partners sale (M&A) as an event-driven catalyst, K-ICS solvency, interest-rate and loss-ratio risk, and mid-cap valuation versus DB Insurance, Hyundai Marine, Meritz and Hanwha.

Lotte Insurance 000400 Korea Stocks

July 31, 2026

Samyang Corporation (145990) Stock Outlook 2026: Sugar Cash Cow Meets Allulose and Specialty Chemicals

Samyang Corporation (KOSPI 145990) 2026 stock outlook for foreign investors. A sum-of-the-parts read on the sugar and starch-sugar food cash cow, global allulose demand, ion-exchange resin and engineering-plastic specialty chemicals, plus raw-sugar cost, holding-company discount and won FX risk.

Samyang Corporation 145990 Korea Stocks

July 31, 2026

INNOX Advanced Materials (272290) Stock Outlook 2026: OLED Material Localization Moat vs the Downstream Cycle

INNOX Advanced Materials (272290) 2026 stock analysis: the OLED heat-dissipation and encapsulation materials localization moat, semiconductor packaging materials, secondary-battery films, foldable and automotive OLED growth, and the display and semiconductor cycle, customer concentration, and long qualification lead-time risks for foreign investors in Korean equities.

INNOX Advanced Materials 272290 OLED materials

July 31, 2026

Sanil Electric (062040) Stock Outlook 2026: A Pure-Play on the US Power-Grid Supercycle

Sanil Electric (062040) 2026 stock analysis: the special-transformer exporter riding US grid replacement, data-center power demand and renewables interconnection, its North American EPC qualification moat, how it stacks up against Hyosung Heavy, HD Hyundai Electric, LS Electric and Jeryong Electric, plus the capex-cycle and valuation risks foreign investors should weigh.

Sanil Electric 062040 transformers

July 31, 2026

MCNEX (097520) Stock Outlook 2026: Automotive Camera Growth Versus the Smartphone Cycle

MCNEX (097520) 2026 stock analysis for foreign investors in Korean equities: smartphone and automotive camera module business, ADAS and autonomous-driving camera content growth, Samsung customer concentration, price-down pressure, and the Partron and Samsung Electro-Mechanics competitive landscape.

MCNEX 097520 camera module

July 30, 2026

Taewoong (044490) Stock Outlook 2026: Free-Forging Moat Meets the Wind and SMR Growth Story

Taewoong 044490 stock outlook 2026 for international investors: a Korean free-forging specialist supplying wind tower flanges and main shafts, an early SMR forged-component contract for a 300MW Canadian reactor, plus the order volatility, steel-plate cost, and CAPEX-cycle risks that define this KOSDAQ name.

Taewoong 044490 Korea stocks

July 30, 2026

Songwon Industrial (004430) Stock Outlook 2026: The World's No. 2 Antioxidant Maker and Its Spread Dilemma

Songwon Industrial (KOSPI 004430) 2026 stock outlook. A deep qualitative look at the global No. 2 polymer antioxidant oligopoly, tin and PVC stabilizers plus specialty chemicals, certification-based switching costs, phenol feedstock spread swings, cyclical thin margins, the comparison with BASF, and a Korea-stock cyclical value lens.

Songwon 004430 Korea Stocks

July 30, 2026

Cosmo Chemical (005420) Stock Outlook 2026: A TiO2 Monopoly, a Loss Cycle, and a Battery Recycling Option

A 2026 stock outlook for Cosmo Chemical (KOSPI 005420), Korea's only titanium dioxide (TiO2) producer. We weigh its domestic monopoly cash cow against a Chinese-driven price war and loss cycle, plus the battery-materials and spent-battery recycling growth option tied to affiliate Cosmo Advanced Materials.

Cosmo Chemical 005420 titanium dioxide

July 30, 2026

Gravity (GRVY / 117730) Stock Outlook 2026: The Ragnarok Single-IP Long Tail and New-Title Risk

Gravity Co. (NASDAQ: GRVY / KOSDAQ: 117730) 2026 stock analysis for global investors: the Ragnarok Online single-IP global long tail across Southeast Asia, Taiwan, and Japan in 91 countries, the mobile-remake-licensing revenue engine, the console Ragnarok project targeting 2027, and the single-IP dependence, hit-driven volatility, small-cap liquidity, and dual-listing dynamics that define this game publisher.

Gravity GRVY Ragnarok

July 30, 2026

Manyo Factory (439090) Stock Outlook 2026: K-Beauty Indie Export Growth vs. Single-Hero-Product Risk

Manyo Factory (KOSDAQ 439090) 2026 stock outlook. A qualitative deep dive into its vegan clean-beauty brand equity and Pure Cleansing Oil hero product, Japan, US and Southeast Asia export channels, asset-light ODM model, reliance on distributors like Silicon2, and marketing-spend and beauty-trend risks for global investors.

Manyo Factory 439090 K-beauty

July 30, 2026

Wontech (336570) Stock Outlook 2026: Oligio Tip Consumables, Razor-Blade Revenue, and the Aesthetic Spending Cycle

A qualitative 2026 outlook on Wontech (KOSDAQ 336570), the Korean energy-based aesthetic device maker behind Oligio monopolar RF and Picocare picosecond lasers. We dissect the razor-blade model of device sales plus recurring tip and cartridge consumables, export expansion across Asia, Europe, the Middle East and Latin America, rivalry with Classys, Jeisys Medical and Lutronic, and the discretionary aesthetic spending risk for Korea-focused investors.

Wontech 336570 Oligio

July 30, 2026

i-SENS (099190) Stock Outlook 2026: A BGM Cash Cow Funding a CGM Growth Option

i-SENS (099190) 2026 stock outlook. A deep qualitative look at the self-monitoring blood glucose (BGM) cash cow, the continuous glucose monitor (CGM) localization and reimbursement growth option, the electrochemical biosensor platform, overseas OEM supply, competition from Abbott Libre and Dexcom, CGM investment losses, and currency risk.

i-SENS 099190 Korea Stocks